OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
hGC33-Modified and Sorafenib-Loaded Nanoparticles have a Synergistic Anti-Hepatoma Effect by Inhibiting Wnt Signaling Pathway
Jing Shen, Wenpeng Cai, Yongfang Ma, et al.
Nanoscale Research Letters (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 18
Jing Shen, Wenpeng Cai, Yongfang Ma, et al.
Nanoscale Research Letters (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 18
Showing 18 citing articles:
Wnt signaling in colorectal cancer: pathogenic role and therapeutic target
Hui Zhao, Tianqi Ming, Shun Tang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 502
Hui Zhao, Tianqi Ming, Shun Tang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 502
Current perspectives and trend of nanomedicine in cancer: A review and bibliometric analysis
Zerong Pei, Shuting Chen, Liqin Ding, et al.
Journal of Controlled Release (2022) Vol. 352, pp. 211-241
Closed Access | Times Cited: 131
Zerong Pei, Shuting Chen, Liqin Ding, et al.
Journal of Controlled Release (2022) Vol. 352, pp. 211-241
Closed Access | Times Cited: 131
Research progress of sorafenib drug delivery system in the treatment of hepatocellular carcinoma: An update
Qiang-qiang Fan, Huan Tian, Jiangxue Cheng, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117118-117118
Open Access | Times Cited: 6
Qiang-qiang Fan, Huan Tian, Jiangxue Cheng, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117118-117118
Open Access | Times Cited: 6
In Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational Modeling
Guilherme Ribeiro Romualdo, Kaat Leroy, Cícero Júlio Silva Costa, et al.
Cancers (2021) Vol. 13, Iss. 21, pp. 5583-5583
Open Access | Times Cited: 34
Guilherme Ribeiro Romualdo, Kaat Leroy, Cícero Júlio Silva Costa, et al.
Cancers (2021) Vol. 13, Iss. 21, pp. 5583-5583
Open Access | Times Cited: 34
Sorafenib-Based Drug Delivery Systems: Applications and Perspectives
Lingyun Wang, Meihuan Chen, Xueguang Ran, et al.
Polymers (2023) Vol. 15, Iss. 12, pp. 2638-2638
Open Access | Times Cited: 14
Lingyun Wang, Meihuan Chen, Xueguang Ran, et al.
Polymers (2023) Vol. 15, Iss. 12, pp. 2638-2638
Open Access | Times Cited: 14
Application of Nanotechnology and Phytochemicals in Anticancer Therapy
Jin Hee Kim, Boluwatife Olamide Dareowolabi, Rekha Thiruvengadam, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1169-1169
Open Access | Times Cited: 5
Jin Hee Kim, Boluwatife Olamide Dareowolabi, Rekha Thiruvengadam, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1169-1169
Open Access | Times Cited: 5
Precision targeting in hepatocellular carcinoma: Exploring ligand-receptor mediated nanotherapy
Xiaqing Zhou, Yaping Li, Shuangsuo Dang
World Journal of Hepatology (2024) Vol. 16, Iss. 2, pp. 164-176
Open Access | Times Cited: 4
Xiaqing Zhou, Yaping Li, Shuangsuo Dang
World Journal of Hepatology (2024) Vol. 16, Iss. 2, pp. 164-176
Open Access | Times Cited: 4
Idarubicin-loaded chitosan nanobubbles to improve survival and decrease drug side effects in hepatocellular carcinoma
Monica Mossenta, Monica Argenziano, Sara Capolla, et al.
Nanomedicine (2025) Vol. 20, Iss. 3, pp. 255-270
Closed Access
Monica Mossenta, Monica Argenziano, Sara Capolla, et al.
Nanomedicine (2025) Vol. 20, Iss. 3, pp. 255-270
Closed Access
Sorafenib—Drug Delivery Strategies in Primary Liver Cancer
Piotr Szyk, Beata Czarczyńska-Goślińska, Marta Ziegler-Borowska, et al.
Journal of Functional Biomaterials (2025) Vol. 16, Iss. 4, pp. 148-148
Open Access
Piotr Szyk, Beata Czarczyńska-Goślińska, Marta Ziegler-Borowska, et al.
Journal of Functional Biomaterials (2025) Vol. 16, Iss. 4, pp. 148-148
Open Access
Investigation of synergistic effects of silver nanoparticles with sorafenib on in vitro prostate and head and neck cancer models
Murat Arslan, Elanur Aydın Karataş
International Journal of Environmental Health Research (2025), pp. 1-9
Closed Access
Murat Arslan, Elanur Aydın Karataş
International Journal of Environmental Health Research (2025), pp. 1-9
Closed Access
Novel Nanotechnology Approaches to Overcome Drug Resistance in the Treatment of Hepatocellular Carcinoma: Glypican 3 as a Useful Target for Innovative Therapies
Monica Mossenta, Davide Busato, Michele Dal Bo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10038-10038
Open Access | Times Cited: 11
Monica Mossenta, Davide Busato, Michele Dal Bo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10038-10038
Open Access | Times Cited: 11
Autophagy up-regulated by MEK/ERK promotes the repair of DNA damage caused by aflatoxin B1
Weiya Cao, Jiafeng Gao, Yinci Zhang, et al.
Toxicology Mechanisms and Methods (2021) Vol. 32, Iss. 2, pp. 87-96
Closed Access | Times Cited: 15
Weiya Cao, Jiafeng Gao, Yinci Zhang, et al.
Toxicology Mechanisms and Methods (2021) Vol. 32, Iss. 2, pp. 87-96
Closed Access | Times Cited: 15
Engineering nanotheranostic strategies for liver cancer
Lei Cao, Yuqin Zhu, Zhixian Wu, et al.
World Journal of Gastrointestinal Oncology (2021) Vol. 13, Iss. 10, pp. 1213-1228
Open Access | Times Cited: 13
Lei Cao, Yuqin Zhu, Zhixian Wu, et al.
World Journal of Gastrointestinal Oncology (2021) Vol. 13, Iss. 10, pp. 1213-1228
Open Access | Times Cited: 13
Nanotherapeutic strategy against glioblastoma using enzyme inhibitors
Rekha Thiruvengadam, Boluwatife Olamide Dareowolabi, Eun‐Yi Moon, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 181, pp. 117713-117713
Open Access | Times Cited: 1
Rekha Thiruvengadam, Boluwatife Olamide Dareowolabi, Eun‐Yi Moon, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 181, pp. 117713-117713
Open Access | Times Cited: 1
ETS-1/c-Met drives resistance to sorafenib in hepatocellular carcinoma.
Yongfang Ma, Xueke Liu, Xiaolong Tang
PubMed (2023) Vol. 15, Iss. 2, pp. 896-913
Closed Access | Times Cited: 3
Yongfang Ma, Xueke Liu, Xiaolong Tang
PubMed (2023) Vol. 15, Iss. 2, pp. 896-913
Closed Access | Times Cited: 3
Nano-revolution in hepatocellular carcinoma: A multidisciplinary odyssey - Are we there yet?
Howard D Lee, Liyun Yuan
World Journal of Hepatology (2024) Vol. 16, Iss. 5, pp. 684-687
Open Access
Howard D Lee, Liyun Yuan
World Journal of Hepatology (2024) Vol. 16, Iss. 5, pp. 684-687
Open Access
Highlighting function of Wnt signalling in urological cancers: Molecular interactions, therapeutic strategies, and (nano)strategies
Mehrdad Hashemi, Mahdi Rezaei, Hadi Rezaeiaghdam, et al.
Translational Oncology (2024) Vol. 50, pp. 102145-102145
Open Access
Mehrdad Hashemi, Mahdi Rezaei, Hadi Rezaeiaghdam, et al.
Translational Oncology (2024) Vol. 50, pp. 102145-102145
Open Access
Antibody-Functionalized Nanoparticles for Targeted Drug Delivery in Cancer Therapy
Ana Camila Marques, Paulo Costa, Sérgia Velho, et al.
Springer eBooks (2023), pp. 1-43
Closed Access
Ana Camila Marques, Paulo Costa, Sérgia Velho, et al.
Springer eBooks (2023), pp. 1-43
Closed Access
